HDs may provide a more functional T cell product and could be screened for a T cell phenotype linked with more potent anti-leukaemia activity such as CD8+CD27+CD45RO– associated with improved response in the setting of CLL [12]. The gene discussed is CD27; the disease is B-cell chronic lymphocytic leukemia.